Results 131 to 140 of about 149,546 (225)

IgA nephropathy management: what does the future hold? [PDF]

Kidney Int Suppl (2011)
Tang SCW, Reich HN.
europepmc   +1 more source

The expanding role of biomarkers in the management of IgA nephropathy. [PDF]

Kidney Int Suppl (2011)
Jain K, Rizk DV.
europepmc   +1 more source

Management of IgA nephropathy and the expanding role of immunomodulation. [PDF]

Kidney Int Suppl (2011)
Canetta PA, Reich HN.
europepmc   +1 more source

Practice Variation in IgA Nephropathy: When the Field Evolves Faster Than Consensus. [PDF]

Kidney360
Vasquez-Rios G, Sanchez-Russo L.
europepmc   +1 more source

IgA nephropathy and the road to motherhood. [PDF]

Clin Kidney J
Stamellou E, Duni A, Dounousi E.
europepmc   +1 more source

Glomerular Basement Membrane Thickness and IgA Nephropathy: A New Wrinkle? [PDF]

Kidney360
Perincheri S.
europepmc   +1 more source

Approved therapies in the IgA nephropathy armamentarium: a summary of the evidence. [PDF]

Kidney Int Suppl (2011)
Norouzi S, Lafayette RA.
europepmc   +1 more source

Autoimmunity in IgA nephropathy. [PDF]

Front Immunol
Nihei Y, Suzuki Y.
europepmc   +1 more source

Individualised treatment effects of corticosteroids in IgA nephropathy. [PDF]

EBioMedicine
Hölscher DL, Schmitz NEJ, Niggemeier L, Pilva P, Strauch M, Tesar V, Barratt J, Roberts ISD, Coppo R, Barisoni L, Yanagita M, Alabalik U, Rule AD, Jagtap JM, Abreu ES, Seikrit C, von Stillfried S, Taal MW, Kalra PA, Floege J, Kramann R, Boor P, Bülow RD, VALIGA investigators, CureGN investigators, NURTuRE academic steering group, AI4IgAN study group.   +26 more
europepmc   +1 more source

Clinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease. [PDF]

Ann Med
Wang A, Shi W, Xu K, Yuan Y, Tang X, Zhao S, Yu D, Liu H, Liu X, Jiang X.   +9 more
europepmc   +1 more source